{"id":23913,"date":"2022-05-09T17:53:10","date_gmt":"2022-05-09T16:53:10","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=23913"},"modified":"2022-05-09T17:53:13","modified_gmt":"2022-05-09T16:53:13","slug":"dim1health-2-0-appel-a-projets-2022","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/","title":{"rendered":"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022"},"content":{"rendered":"\n<p><a href=\"https:\/\/dim1health2022fonc.sciencescall.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Cet appel \u00e0 projets<\/a> permettra de financer :<\/p>\n\n\n\n<p>des allocations doctorales et post-doctorales ou un poste d&#8217;ing\u00e9nieur d&#8217;\u00e9tudes<\/p>\n\n\n\n<ul><li>au maximum une allocation doctorale (36 mois) (un co-financement peut \u00eatre apport\u00e9) ou une allocation post-doctorante (24 mois) ou un financement d&#8217;ing\u00e9nieur d&#8217;\u00e9tudes travaillant sur une plateforme (24 mois)<\/li><li>et une subvention d\u2019investissement pour l&#8217;achat d\u2019\u00e9quipement(s) n\u00e9cessaire(s) \u00e0 la bonne conduite du projet dont le co\u00fbt total est de 5 \u00e0 50 K\u20ac HT. Ils seront financ\u00e9s par la R\u00e9gion \u00cele-de-France avec un taux d\u2019intervention maximum de 66% des d\u00e9penses HT. Un co-financement de 34% devra donc \u00eatre justifi\u00e9 dans la demande.<\/li><li>Une aide \u00e0 la valorisation d\u2019un montant maximal de 20k\u20ac. Des manifestations scientifiques<\/li><li>l&#8217;objectif est d&#8217;aider au rayonnement scientifique international de la recherche francilienne et favoriser les \u00e9changes scientifiques entre \u00e9quipes de recherche internationales, par le soutien aux manifestations scientifiques.<\/li><li>Le financement allou\u00e9 par la R\u00e9gion \u00cele-de-France n\u2019est en aucun cas sup\u00e9rieur \u00e0 50% du budget total HT.<\/li><\/ul>\n\n\n\n<p>Chaque projet soumis au DIM-1HEALTH 2.0 devra \u00eatre associ\u00e9 \u00e0 au moins l&#8217;un des axes th\u00e9matiques d\u00e9crits pr\u00e9c\u00e9demment. Tous les champs de recherche peuvent \u00eatre consid\u00e9r\u00e9s (Sciences biologiques, recherche appliqu\u00e9e, sciences sociales, mod\u00e9lisation,\u2026).<\/p>\n\n\n\n<p>La s\u00e9lection sera faite sur la qualit\u00e9 scientifique des projets associ\u00e9s \u00e0 la demande, la plus-value scientifique de l\u2019investissement propos\u00e9, sa coh\u00e9rence avec les axes du DIM et du concept \u00ab Un monde, une sant\u00e9 \u00bb, son caract\u00e8re structurant pour la communaut\u00e9 scientifique et sa valorisation par des applications concr\u00e8tes, (valorisation possible \u00e0 court terme, cr\u00e9ation de startup\u2026.).<\/p>\n\n\n\n<p>Modalit\u00e9s de l\u2019appel \u00e0 projets du DIM-1HEALTH 2.0 :<\/p>\n\n\n\n<ul><li>aucune pr\u00e9s\u00e9lection ne sera demand\u00e9e \u00e0 l&#8217;organisme de rattachement ;<\/li><li>l&#8217;appel \u00e0 projets doctorant sera effectu\u00e9 en \u00e9troite interaction avec les \u00e9coles doctorales franciliennes qui recevront le nom des candidats et les projets d\u00e9pos\u00e9s.<\/li><li>tous les projets \u00e9ligibles seront \u00e9valu\u00e9s par des experts situ\u00e9s hors \u00cele-de-France ;<\/li><li>ces projets seront examin\u00e9s par le Comit\u00e9 Scientifique Elargi (CSE) du DIM, et le classement sera soumis au vote du Conseil d\u2019Administration (CA) du DIM ; les demandes de financement pour les projets s\u00e9lectionn\u00e9s par le DIM seront soumises au vote des \u00e9lus de la R\u00e9gion.<\/li><\/ul>\n\n\n\n<p>NB: les \u00e9quipes ayant obtenu une subvention dans la derni\u00e8re ann\u00e9e du DIM One Health ne sont pas \u00e9ligibles \u00e0 un financement en 2022 par le DIM One Health 2.0<\/p>\n\n\n\n<p>IMPORTANT : Un second appel d&#8217;offres sera lanc\u00e9 d&#8217;ici l&#8217;\u00e9t\u00e9 et visera \u00e0 financer des projets d&#8217;investissement.<\/p>\n\n\n\n<p>Plus sur le site de <a href=\"https:\/\/dim1health2022fonc.sciencescall.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">DIM1HEALTH<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cet appel \u00e0 projets permettra de financer : des allocations doctorales et post-doctorales ou un poste d&#8217;ing\u00e9nieur d&#8217;\u00e9tudes au maximum une allocation doctorale (36 mois) (un co-financement peut \u00eatre apport\u00e9) ou une allocation post-doctorante (24 mois) ou un financement d&#8217;ing\u00e9nieur d&#8217;\u00e9tudes travaillant sur une plateforme (24 mois) et une subvention d\u2019investissement pour l&#8217;achat d\u2019\u00e9quipement(s) n\u00e9cessaire(s) [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":23919,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[59],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>DIM1HEALTH 2.0 : Appel \u00e0 projets 2022 - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022 - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-09T16:53:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-09T16:53:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"602\" \/>\n\t<meta property=\"og:image:height\" content=\"606\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022\",\"datePublished\":\"2022-05-09T16:53:10+00:00\",\"dateModified\":\"2022-05-09T16:53:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\"},\"wordCount\":428,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg\",\"articleSection\":[\"Calls for projects\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\",\"name\":\"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022 - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg\",\"datePublished\":\"2022-05-09T16:53:10+00:00\",\"dateModified\":\"2022-05-09T16:53:13+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg\",\"width\":602,\"height\":606,\"caption\":\"Cr\u00e9dit : Inserm\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Calls for projects\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022 - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/","og_locale":"en_GB","og_type":"article","og_title":"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022 - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-05-09T16:53:10+00:00","article_modified_time":"2022-05-09T16:53:13+00:00","og_image":[{"width":602,"height":606,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022","datePublished":"2022-05-09T16:53:10+00:00","dateModified":"2022-05-09T16:53:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/"},"wordCount":428,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg","articleSection":["Calls for projects"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/","name":"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022 - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg","datePublished":"2022-05-09T16:53:10+00:00","dateModified":"2022-05-09T16:53:13+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/DIM1HEALTH2.0.jpg","width":602,"height":606,"caption":"Cr\u00e9dit : Inserm"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/dim1health-2-0-appel-a-projets-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"Calls for projects","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/"},{"@type":"ListItem","position":4,"name":"DIM1HEALTH 2.0 : Appel \u00e0 projets 2022"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-20 19:29:37","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/23913"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=23913"}],"version-history":[{"count":10,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/23913\/revisions"}],"predecessor-version":[{"id":23937,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/23913\/revisions\/23937"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/23919"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=23913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=23913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=23913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}